MAPK1 and acute respiratory distress syndrome: Activation of cPLA2, the rate-limiting enzyme in arachidonic acid synthesis, has been implicated in the pathogenesis of human ARDS and experimental VILI [51,52] and thrombin is an important activator of cPLA2 downstream of ERK [53].